Wojcicki: How 23andMe Disrupts Health Care With DNA

Wojcicki: How 23andMe Disrupts Health Care With DNA Play

Nov. 26 (Bloomberg) -- Anne Wojcicki, CEO & co-founder at 23andMe, discusses the company’s battle with the FDA over their $99 DNA testing product and the company’s plans for growth using big data. She speaks on Bloomberg Television’s “Market Makers.”

  • On Air Now

    Bloomberg Surveillance Watch Now

  • Next

    In The Loop with Betty Liu

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus